ONCONETIX - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Serial Number
98267927
Word Mark
ONCONETIX
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2023-12-16
Filing Date
2023-11-13
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Statements
Goods and Services
Pharmaceuticals; pharmaceuticals, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics; diagnostics; diagnostics, namely, in-vitro, in-vivo, and cell-based assays, cell culture processes, laboratory-developed tests (LDTs), cell-based imagining, genomics, gene-based expression assays, proteomics, protein-based expression assays, immunohistochemistry (IHC), drug sensitivity and treatment diagnostics, diagnostic algorithms and decision-making computational software to support screening, diagnosing, monitoring and treatment modalities; medical devices; medical devices, namely, devices that deliver therapeutic drugs of various types, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics, into the human body utilizing both in-vivo and in-vitro (gene or cellular therapies) methods for personalized medical therapeutics; Computational, Software, and decision systems; computational, software, and decision systems, namely, products and services for clinical and after-regulatory approval of both therapeutics and diagnostics (theranostics) that support and maintain pre-clinical trials, clinical trials and assessments of patient's tumors in their staging and treatment; Biobanking and Research; biobanking and research, namely, acquisition, processing, analysis, and storage of human and animal specimens in a biobanking facility that is used for personalized medicine with patient treatment (therapeutics and diagnostics). Digital Pathology and other imaging and cellular systems for the characterization of human and animal tumors
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2023-12-16
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DANIELLE COHEN, ESQ.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2023-12-16 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |